ATE244262T1 - Verfahren zur herstellung von peptidzwischenprodukten - Google Patents

Verfahren zur herstellung von peptidzwischenprodukten

Info

Publication number
ATE244262T1
ATE244262T1 AT00968148T AT00968148T ATE244262T1 AT E244262 T1 ATE244262 T1 AT E244262T1 AT 00968148 T AT00968148 T AT 00968148T AT 00968148 T AT00968148 T AT 00968148T AT E244262 T1 ATE244262 T1 AT E244262T1
Authority
AT
Austria
Prior art keywords
intermediate products
peptide intermediate
producing peptide
synthesis
producing
Prior art date
Application number
AT00968148T
Other languages
English (en)
Inventor
Michael Stewart Ashwood
Christopher Brian Bishop
Ian Frank Cottrell
Khateeta Moneek Emerson
David Hands
Guo-Jie Ho
Joseph Edward Lynch
Yao-Jun Shi
Robert Darrin Wilson
Original Assignee
Merck Sharp & Dohme
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme, Merck & Co Inc filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE244262T1 publication Critical patent/ATE244262T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/42—Glutaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00968148T 1999-10-19 2000-10-18 Verfahren zur herstellung von peptidzwischenprodukten ATE244262T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924759.5A GB9924759D0 (en) 1999-10-19 1999-10-19 Process for preparing peptide intermediates
PCT/GB2000/004019 WO2001029065A1 (en) 1999-10-19 2000-10-18 Process for preparing peptide intermediates

Publications (1)

Publication Number Publication Date
ATE244262T1 true ATE244262T1 (de) 2003-07-15

Family

ID=10863015

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00968148T ATE244262T1 (de) 1999-10-19 2000-10-18 Verfahren zur herstellung von peptidzwischenprodukten

Country Status (10)

Country Link
US (1) US7262169B1 (de)
EP (1) EP1226158B1 (de)
JP (1) JP2003516319A (de)
AT (1) ATE244262T1 (de)
AU (1) AU7810000A (de)
CA (1) CA2387995A1 (de)
DE (1) DE60003711T2 (de)
ES (1) ES2200951T3 (de)
GB (1) GB9924759D0 (de)
WO (1) WO2001029065A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1094601A (en) * 1999-10-19 2001-04-30 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
EP3265109B1 (de) 2015-03-06 2020-10-21 Stealth BioTherapeutics Corp Verfahren zur herstellung von pharmazeutisch relevanten peptiden
EP4201951B1 (de) * 2021-12-21 2023-11-22 Bachem Holding AG Verfahren zur peptidsynthese

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376765A (en) 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
FR2546163B1 (fr) 1983-05-16 1987-10-09 Centre Nat Rech Scient Nouveaux derives acyles hydrosolubles de peptides ou d'amino-acides, leur preparation et leur application
US6143864A (en) 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
PT769967E (pt) 1994-08-19 2008-02-18 Univ Catholique Louvain Conjugados que compreendem um agente antitumoral e a sua utilização
EP0926955A4 (de) 1996-09-12 2003-05-07 Merck & Co Inc Konjugate nützlich in die behandlung von prostatakarzinom
HRP970566A2 (en) * 1996-10-30 1998-08-31 Jones Deborah Defeo Conjugates useful in the treatment of prostate canser
ATE256473T1 (de) * 1997-07-10 2004-01-15 Merck & Co Inc Konjugate welche bei der behandlung von prostatakrebs nützlich sind
IL136167A0 (en) * 1997-12-02 2001-05-20 Merck & Co Inc Conjugates useful in the treatment of prostate cancer
AU749063B2 (en) * 1998-03-05 2002-06-20 Merck & Co., Inc. Conjugates useful in the treatment of prostrate cancer
AU1094601A (en) * 1999-10-19 2001-04-30 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer

Also Published As

Publication number Publication date
JP2003516319A (ja) 2003-05-13
US7262169B1 (en) 2007-08-28
WO2001029065A1 (en) 2001-04-26
EP1226158B1 (de) 2003-07-02
DE60003711T2 (de) 2004-05-13
ES2200951T3 (es) 2004-03-16
DE60003711D1 (de) 2003-08-07
GB9924759D0 (en) 1999-12-22
CA2387995A1 (en) 2001-04-26
EP1226158A1 (de) 2002-07-31
AU7810000A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
NO20031687D0 (no) Veksthormonsekretagoger
EA200200940A1 (ru) Производные азетидина, способ их получения и содержащие их фармацевтические композиции
BR0111230A (pt) Composto, e, uso e processo para a preparação do mesmo
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
EA200300579A1 (ru) Соединение лактама
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
TR199800543A2 (xx) Benziloksi ikame edilen, aniliye edilmi� N-heterosiklik bile�ikler.
UA66866C2 (uk) Синтез морфолінових похідних
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
EA200100213A1 (ru) Способ синтеза производных (1h)-бензо[c]хинолизин-3-онов
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
MXPA05011289A (es) Compuestos de fosfato que tienen actividad inmunomoduladora.
ATE244262T1 (de) Verfahren zur herstellung von peptidzwischenprodukten
ATE208381T1 (de) Verfahren zur herstellung von taxol und seiner derivate
ATE223414T1 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
ATE300534T1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
ATE399757T1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
ATE277051T1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
ATE425143T1 (de) Verfahren zur herstellung von indolen
DE60306361D1 (de) Verfahren zur herstellung von benazeprilhydrochloride

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties